tiprankstipranks
Actinium Pharmaceuticals (ATNM)
:ATNM
US Market
ATNM
Actinium Pharmaceuticals
RESEARCH TOOLSreports

Actinium Pharmaceuticals (ATNM) Income Statement

2,270 Followers

Actinium Pharmaceuticals Income Statement

Last quarter (Q4 2025), Actinium Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Actinium Pharmaceuticals's net income was $-5.94M. See Actinium Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Dec 21
Total Revenue
$ 90.00K$ 0.00$ 81.00K$ 1.03M$ 1.14M
Gross Profit
$ 90.00K$ -811.00K$ 81.00K$ 1.03M$ 620.00K
Operating Expenses
$ 36.34M$ 41.31M$ 52.00M$ 35.13M$ 25.58M
Depreciation and Amortization
$ 821.00K$ 811.00K$ 790.00K$ 699.00K$ 524.00K
EBITDA
$ -36.25M$ -37.43M$ -51.13M$ -33.41M$ -24.25M
Operating Income
$ -36.25M$ -42.12M$ -51.92M$ -34.10M$ -24.96M
Other Income/Expenses
$ 2.36M$ 3.88M$ 3.10M$ 1.09M$ 190.00K
Pretax Income
$ -33.89M$ -38.24M$ -48.82M$ -33.02M$ -24.77M
Net Income
$ -33.89M$ -38.24M$ -48.82M$ -33.02M$ -24.77M
Per Share Metrics
Basic EPS
$ -1.09$ -1.27$ -1.83$ -1.37$ -1.20
Diluted EPS
$ -1.09$ -1.27$ -1.83$ -1.37$ -1.20
Weighted Average Shares Outstanding
 31.20M 30.07M 26.60M 24.14M 20.57M
Weighted Average Shares Outstanding (Diluted)
 31.20M 30.07M 26.60M 24.14M 20.57M
Currency in USD

Actinium Pharmaceuticals Earnings and Revenue History